TrialAllergy2025

Integrated Efficacy and Safety Analysis of Abrocitinib in Adolescents With Moderate-to-Severe Atopic Dermatitis.

Amy S Paller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.